ATXS logo

Astria Therapeutics (ATXS) Selling, General & Administrative Expenses

Annual SGA

$25.70 M
+$6.46 M+33.60%

December 31, 2023

Summary

Performance

1-Year Change

+33.6%

3-Year Change

+117%

5-Year Change

+175.53%

15-Year Change

+188.42%

ATXS SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.3%
ATXS annual SGA is higher than 46.3% of companies in Healthcare sector

High & Low

All-time High

$25.70 M
ATXS annual SGA is currently at an all-time high

3-Year Low

$14.81 M
ATXS annual SGA is currently +73.59% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ATXS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 4, 2025
ATXS next annual earnings announcement is scheduled for Mar 4, 2025

OtherATXSexpensesmetrics:

Annual Total Expenses

$67.83 M
ATXS annual total expenses is $67.83 million

Annual Operating Expenses

$67.83 M
ATXS annual total operating expenses is $67.83 million

Annual Cost Of Goods Sold

-
ATXS annual cost of goods sold value is unknown

Annual Interest Expense

-
ATXS annual interest expense value is unknown

Quarterly SGA

$8.50 M
+$410.00 K+5.07%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

ATXS Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.19%
ATXS quarterly SGA is higher than 51.19% of companies in Healthcare sector

High & Low

All-time High

$8.50 M
ATXS quarterly SGA is currently at an all-time high

3-Year Low

$3.81 M
ATXS quarterly SGA is currently +122.91% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ATXS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 4, 2025
ATXS next earnings announcement is scheduled for Mar 4, 2025

OtherATXSexpensesmetrics:

Quarterly Total Expenses

$29.01 M
ATXS quarterly total expenses is $29.01 million

Quarterly Operating Expenses

$29.01 M
ATXS quarterly total operating expenses is $29.01 million

Quarterly Cost Of Goods Sold

-
ATXS quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
ATXS quarterly interest expense value is unknown

TTM SGA

-$2.45 B
-$100.04 M-4.25%

September 30, 2024

Summary

Performance

3-Month Change

-7687.07%

1-Year Change

-7687.07%

3-Year Change

-7687.07%

5-Year Change

-7687.07%

ATXS TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.09%
ATXS TTM SGA is higher than 19.09% of companies in Healthcare sector

High & Low

All-time High

-$75.38 M

3-Year Low

-$2.45 B
ATXS TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ATXS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 4, 2025
ATXS next earnings announcement is scheduled for Mar 4, 2025

OtherATXSexpensesmetrics:

Annual Total Expenses

$67.83 M
ATXS annual total expenses is $67.83 million

Annual Operating Expenses

$67.83 M
ATXS annual total operating expenses is $67.83 million

TTM Cost Of Goods Sold

-
ATXS TTM cost of goods sold value is unknown

TTM Interest Expense

-
ATXS TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$25.70 M
ATXS annual SGA is $25.70 million

Annual Operating Expenses

$67.83 M
ATXS annual total operating expenses is $67.83 million

Annual Cost Of Goods Sold

-
ATXS annual cost of goods sold value is unknown

ATXS Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+33.6%0.0%-7687.1%
3 y3 years+117.0%0.0%-7687.1%
5 y5 years+175.5%0.0%-7687.1%

ATXS Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+73.6%at high+122.9%-38.6%at low
5 y5-yearat high+193.1%at high+242.3%-187.3%at low
alltimeall timeat high+523.1%at high+519.4%-3156.6%at low

Astria Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$8.50 M(+5.1%)
$32.35 M(+5.2%)
Jun 2024
-
$8.09 M(-3.9%)
$30.75 M(+7.3%)
Mar 2024
-
$8.42 M(+14.9%)
$28.67 M(+11.5%)
Dec 2023
$25.70 M(+33.6%)
$7.33 M(+6.3%)
$25.70 M(+11.4%)
Sep 2023
-
$6.90 M(+14.7%)
$23.07 M(+10.6%)
Jun 2023
-
$6.01 M(+10.1%)
$20.86 M(+6.0%)
Mar 2023
-
$5.46 M(+16.2%)
$19.68 M(+2.3%)
Dec 2022
$19.24 M(+29.9%)
$4.70 M(+0.2%)
$19.24 M(+4.8%)
Sep 2022
-
$4.69 M(-3.0%)
$18.36 M(+3.3%)
Jun 2022
-
$4.83 M(-3.7%)
$17.78 M(+4.9%)
Mar 2022
-
$5.02 M(+31.6%)
$16.95 M(+14.4%)
Dec 2021
$14.81 M(+25.0%)
$3.81 M(-7.2%)
$14.81 M(+4.1%)
Sep 2021
-
$4.11 M(+2.5%)
$14.23 M(+8.0%)
Jun 2021
-
$4.01 M(+39.2%)
$13.18 M(+10.1%)
Mar 2021
-
$2.88 M(-10.9%)
$11.97 M(+1.1%)
Dec 2020
$11.85 M(+35.0%)
$3.23 M(+5.8%)
$11.85 M(+6.7%)
Sep 2020
-
$3.06 M(+9.1%)
$11.10 M(+10.7%)
Jun 2020
-
$2.80 M(+1.8%)
$10.03 M(+6.8%)
Mar 2020
-
$2.75 M(+10.8%)
$9.39 M(+7.0%)
Dec 2019
$8.77 M
$2.48 M(+25.1%)
$8.77 M(+0.6%)
Sep 2019
-
$1.99 M(-8.3%)
$8.72 M(-1.4%)
Jun 2019
-
$2.17 M(+1.3%)
$8.84 M(-2.6%)
DateAnnualQuarterlyTTM
Mar 2019
-
$2.14 M(-12.0%)
$9.07 M(-2.7%)
Dec 2018
$9.33 M(+4.7%)
$2.43 M(+15.1%)
$9.33 M(+8.2%)
Sep 2018
-
$2.11 M(-11.9%)
$8.62 M(-3.5%)
Jun 2018
-
$2.40 M(+0.2%)
$8.94 M(-0.0%)
Mar 2018
-
$2.39 M(+38.8%)
$8.94 M(+0.3%)
Dec 2017
$8.91 M(-11.8%)
$1.72 M(-29.0%)
$8.91 M(-7.2%)
Sep 2017
-
$2.43 M(+1.1%)
$9.60 M(+0.8%)
Jun 2017
-
$2.40 M(+1.6%)
$9.52 M(-1.8%)
Mar 2017
-
$2.36 M(-2.1%)
$9.70 M(-4.0%)
Dec 2016
$10.11 M(+17.1%)
$2.41 M(+2.8%)
$10.11 M(-2.4%)
Sep 2016
-
$2.35 M(-9.0%)
$10.36 M(-0.4%)
Jun 2016
-
$2.58 M(-6.9%)
$10.40 M(+7.7%)
Mar 2016
-
$2.77 M(+4.0%)
$9.65 M(+11.9%)
Dec 2015
$8.63 M(+43.9%)
$2.66 M(+11.5%)
$8.63 M(+14.8%)
Sep 2015
-
$2.39 M(+30.3%)
$7.52 M(+14.7%)
Jun 2015
-
$1.83 M(+5.1%)
$6.56 M(+3.0%)
Mar 2015
-
$1.74 M(+12.4%)
$6.37 M(+6.2%)
Dec 2014
$6.00 M(+45.3%)
$1.55 M(+8.8%)
$5.99 M(+34.9%)
Sep 2014
-
$1.43 M(-13.1%)
$4.44 M(+47.3%)
Jun 2014
-
$1.64 M(+19.6%)
$3.02 M(+119.6%)
Mar 2014
-
$1.37 M
$1.37 M
Dec 2013
$4.13 M
-
-

FAQ

  • What is Astria Therapeutics annual SGA?
  • What is the all time high annual SGA for Astria Therapeutics?
  • What is Astria Therapeutics annual SGA year-on-year change?
  • What is Astria Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Astria Therapeutics?
  • What is Astria Therapeutics quarterly SGA year-on-year change?
  • What is Astria Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Astria Therapeutics?
  • What is Astria Therapeutics TTM SGA year-on-year change?

What is Astria Therapeutics annual SGA?

The current annual SGA of ATXS is $25.70 M

What is the all time high annual SGA for Astria Therapeutics?

Astria Therapeutics all-time high annual SGA is $25.70 M

What is Astria Therapeutics annual SGA year-on-year change?

Over the past year, ATXS annual SGA has changed by +$6.46 M (+33.60%)

What is Astria Therapeutics quarterly SGA?

The current quarterly SGA of ATXS is $8.50 M

What is the all time high quarterly SGA for Astria Therapeutics?

Astria Therapeutics all-time high quarterly SGA is $8.50 M

What is Astria Therapeutics quarterly SGA year-on-year change?

Over the past year, ATXS quarterly SGA has changed by $0.00 (0.00%)

What is Astria Therapeutics TTM SGA?

The current TTM SGA of ATXS is -$2.45 B

What is the all time high TTM SGA for Astria Therapeutics?

Astria Therapeutics all-time high TTM SGA is -$75.38 M

What is Astria Therapeutics TTM SGA year-on-year change?

Over the past year, ATXS TTM SGA has changed by -$2.49 B (-7687.07%)